Varicose Veins Treatment Market Share & Size Analysis 2028

Summary

Report Description

Global Varicose Veins Treatment Market is anticipated to witness the growth of steady CAGR in the forecast period, 2024-2028. It can be ascribed to the rising advanced varicose vein treatment devices escalating the market growth. Besides, surging preference for minimally invasive treatment procedures is expected to drive the growth of global varicose vein treatment market. Additionally, the availability of advanced varicose vein treatment devices is further expected to support the market growth. Moreover, rise in the technological advancements and modernization in the healthcare devices, rise in the research and development activities in the healthcare sector will further create new opportunities for the varicose vein treatment market in the forecasted period. On the contrary, growing R&D and rise in awareness among healthcare professionals as well as patients regarding varicose vein treatment are expected to create lucrative opportunities in future. Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25–40% and 10–20% in women and men, respectively. The annual incidence is 2–6% in women and 1.9% in men. Moreover, advances in medical technology have led to the development of more effective and minimally invasive treatment options. These treatments, which include endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and sclerotherapy, are becoming increasingly popular among patients due to their effectiveness, safety, and minimal downtime. Another factor contributing to the growth of the varicose veins treatment market is the increasing awareness about the condition and available treatment options. Healthcare professionals and organizations are actively promoting the importance of early detection and treatment of varicose veins, which is driving patient demand for these treatments. Compression stockings are specially designed stockings that apply pressure to the legs, helping to improve blood flow and prevent the pooling of blood in the veins. These stockings are often the first line of treatment for varicose veins and are available in different strengths and styles. Phlebotonics are medicines that improve the tone and elasticity of the veins, reducing inflammation and pain. They are often used in combination with other treatments. Anticoagulants are medicines that help to prevent blood clots from forming in the veins, reducing the risk of complications such as deep vein thrombosis. There is a lack of awareness among the general population about the symptoms, causes, and treatment options for varicose veins. This results in many people delaying seeking medical attention or not receiving proper treatment, which can lead to complications and the worsening of the condition. The cost of varicose veins treatment can be high, particularly in developed countries where healthcare costs are generally higher. This can make it difficult for some patients to access treatment, particularly if they are uninsured or underinsured. There are several alternative treatments available for varicose veins, including home remedies, herbal remedies, and traditional medicine. These alternative treatments may be less effective than traditional medical treatments, but they can be more affordable and accessible to some patients.

Rising Prevalence of Venous Disorders

Increasing awareness and rising prevalence of varicose veins are subsequently boosting the market growth. Various governmental and non-governmental organizations are taking initiatives to create awareness about the venous diseases and the availability of advanced therapies for its treatment. For instance, in the U.S., recently, the Society for Vascular Surgery and the American Venous Forum issued recommendations for the diagnosis of varicose veins for clinical care. In the U.S. alone, about 30 million people are suffering from varicose veins every year, out of which, only 10% of the people seek treatment. Obesity, particularly amongst women, prolonged standing hours at work, and smoking, are some of the significant risk factors associated with the development of varicose veins. Additionally, varicose veins are observed to be diagnosed during pregnancies due to the enlargement of the gravid uterus, which results in hypertension and distension in the lower-extremity veins and an increase in hormone secretion, leading to the weakening of the venous walls. Varicose vein is most prevalent in the geriatric population, moreover, rising in geriatric population anticipated to boost the market. It is estimated that 41% of women over the age of 50 have varicose veins. It is estimated that 50% of the US population over 50 years old has varicose veins. Women who are moderately overweight (BMI 25-29.9) have a 50% increased risk of developing varicose veins compared to women who are not overweight. Obesity is another significant risk factor for varicose veins. The increasing prevalence of obesity in many parts of the world has contributed to the rising incidence of varicose veins. Genetics plays a role in the development of varicose veins, and a family history of the condition is a risk factor. As more people with a genetic predisposition to varicose veins have children, the prevalence of the condition is likely to increase. Environmental factors, such as exposure to heat or standing for long periods, can increase the risk of varicose veins. As global temperatures rise and more people work in occupations that require long periods of standing, the prevalence of varicose veins may increase. There is an increasing awareness about the importance of early detection and treatment of varicose veins among patients and healthcare professionals. This has led to a growing demand for treatment options, which is driving the growth of the market.

Technological Advancements

The global market is likely to be driven by continuous advancements in varicose veins treatment devices and an increase in the incidence of varicose veins illness. The use of a compression device to treat varicose veins has grown in popularity because it improves blood circulation by applying mild pressure. In addition, various advantages of Laser treatment, such as painless 30 minutes procedure, minimal risk of reoccurrence, minimum invasion, quick recovery, etc., are predicted to help the growth of the Varicose Veins Treatment Market over the projection year. According to the Occupational Safety and Health Research Institute, the prevalence of lower limb varicose veins varies between 10% and 30% globally. Furthermore, in the forecasted period, technical improvements and modernization in healthcare devices increased research and development efforts in the healthcare sector. Increased growth in emerging regions will generate lucrative growth opportunities for the Varicose Veins Treatment Market shortly. The development of new and innovative treatment options, such as endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and sclerotherapy, has revolutionized the treatment of varicose veins. These minimally invasive treatment options offer several advantages over traditional surgical methods, such as reduced recovery time and minimal scarring. Technological advancements in imaging and diagnostics have enabled healthcare professionals to diagnose and treat varicose veins more accurately and efficiently. This has led to an increase in the success rates of varicose veins treatments and a higher level of patient satisfaction. One of the most significant developments in the treatment of varicose veins is the increased use of endovenous thermal ablation techniques. These techniques involve the use of heat energy to close off damaged veins, and they are less invasive than traditional surgical methods. In recent years, several new endovenous thermal ablation techniques have been introduced, including steam vein sclerosis, which uses steam to close off damaged veins. Another new treatment option for varicose veins is cyanoacrylate glue closure. This technique involves the use of medical-grade glue to close off damaged veins, and it has been found to be both safe and effective. One example of a recent advancement in varicose veins treatment is the use of VenaSeal, a medical adhesive that is used to close off damaged veins. VenaSeal has been shown to be safe and effective in clinical studies and is less invasive than traditional surgical methods. Another recent development is the use of radiofrequency ablation (RFA) and laser ablation techniques. RFA and laser ablation use heat energy to close off damaged veins, and they are less invasive than traditional surgical methods. These techniques have been found to be both safe and effective and offer patients a quicker recovery time.

Recent Development

HERACLION (ISIN: FR0010120402; Mnemo: ALTHE, PEA-PME eligible) (Paris:ALTHE), an innovative company specialized in echotherapy treatment (using High Intensity Focused Ultrasound or HIFU), has obtained CE Mark for the second generation of SONOVEIN®, it’s HIFU treatment solution for varicose veins. It has also signed a strategic supplier partnership with SuperSonic Imaging (part of Hologic Inc.). Theraclion’s ambition is to give all patients access to non-invasive varicose vein treatments.

Download Free Sample Report

Market Segmentation

The Global Varicose Veins Treatment market is segmented based on type, component, end user, and region. Based on type, the market can be segmented into Endovenous Ablation, Sclerotherapy, Surgical Ligation, and Stripping. Based on component, the market can be differentiated into Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, and Others. Based on end user, the market can be differentiated into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa and South America. In terms of country, among United States, North American region is dominating the overall globe in the varicose vein treatment market. Approximately 23% of US adults have varicose veins. If spider telangiectasias and reticular veins are also considered, the prevalence increases to 80% of men and 85% of women.

Market Players

Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc., Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System), are some of the leading players operating in the Global Varicose Veins Treatment Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· By Type · By Component · By End User · By Region
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE
Key companies profiled	Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc, Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System)
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Varicose Veins Treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Varicose Veins Treatment Market, By Type:

Endovenous Ablation
Sclerotherapy
Surgical Ligation
Stripping

Varicose Veins Treatment Market, By Component:

o Ablation Devices

o Radiofrequency Ablation Devices

o Laser Ablation Devices

o Venous Closure Products

o Others

Varicose Veins Treatment Market, By End User:

o Hospitals & Clinics

o Ambulatory Care Centers

o Others

Varicose Veins Treatment Market, By Region:

North America

United States
Mexico
Canada

Europe

France
Germany
United Kingdom
Italy
Spain

Asia Pacific

China
India
Japan
South Korea
Australia

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Varicose Veins Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Varicose Veins TreatmentMarket is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Varicose Veins Treatment Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping)

5.2.2. By Component (Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, Others)

5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

5.2.4. By Region

5.2.5. By Company (2022)

5.3. Market Map

5.3.1. By Type

5.3.2. By Component

5.3.3. By End User

5.3.4. By Region

6. North America Varicose Veins Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

6.2.2. By Component

6.2.3. By End User

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Varicose Veins Treatment Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Type

6.3.1.2.2. By Component

6.3.1.2.3. By End User

6.3.2. Mexico Varicose Veins Treatment Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Type

6.3.2.2.2. By Component

6.3.2.2.3. By End User

6.3.3. Canada Varicose Veins Treatment Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Type

6.3.3.2.2. By Component

6.3.3.2.3. By End User

7. Europe Varicose Veins Treatment Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

7.2.2. By Component

7.2.3. By End User

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. France Varicose Veins Treatment Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. By Component

7.3.1.2.3. By End User

7.3.2. Germany Varicose Veins Treatment Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type

7.3.2.2.2. By Component

7.3.2.2.3. By End User

7.3.3. United Kingdom Varicose Veins Treatment Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type

7.3.3.2.2. By Component

7.3.3.2.3. By End User

7.3.4. Italy Varicose Veins Treatment Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Type

7.3.4.2.2. By Component

7.3.4.2.3. By End User

7.3.5. Spain Varicose Veins Treatment Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Type

7.3.5.2.2. By Component

7.3.5.2.3. By End User

8. Asia-Pacific Varicose Veins Treatment Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By Component

8.2.3. By End User

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Varicose Veins Treatment Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. By Component

8.3.1.2.3. By End User

8.3.2. India Varicose Veins Treatment Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. By Component

8.3.2.2.3. By End User

8.3.3. Japan Varicose Veins Treatment Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. By Component

8.3.3.2.3. By End User

8.3.4. South Korea Varicose Veins Treatment Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type

8.3.4.2.2. By Component

8.3.4.2.3. By End User

8.3.5. Australia Varicose Veins Treatment Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type

8.3.5.2.2. By Component

8.3.5.2.3. By End User

9. South America Varicose Veins Treatment Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type

9.2.2. By Component

9.2.3. By End User

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Varicose Veins Treatment Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. By Component

9.3.1.2.3. By End User

9.3.2. Argentina Varicose Veins Treatment Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. By Component

9.3.2.2.3. By End User

9.3.3. Colombia Varicose Veins Treatment Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. By Component

9.3.3.2.3. By End User

10. Middle East and Africa Varicose Veins Treatment Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type

10.2.2. By Component

10.2.3. By End User

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Varicose Veins Treatment Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. By Component

10.3.1.2.3. By End User

10.3.2. Saudi Arabia Varicose Veins Treatment Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. By Component

10.3.2.2.3. By End User

10.3.3. UAE Varicose Veins Treatment Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. By Component

10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Competitive Landscape

13.1. Business Overview

13.2. Company Snapshot

13.3. Products & Services

13.4. Financials (As reported)

13.5. Recent Developments

13.6. SWOT Analysis

13.6.1. Alma Lasers Limited

13.6.2. Medtronic Plc.

13.6.3. Boston Scientific Corporation (Lumenis Corporation)

13.6.4. Sciton, Inc

13.6.5. Merit Medical Systems, Inc.

13.6.6. BTG International Limited

13.6.7. Energist Limited

13.6.8. Teleflex Incorporated

13.6.9. AngioDynamics, Inc.

13.6.10. El. En SpA Group (Quanta System)

Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Varicose Veins Treatment Market?

The growing preference of the general population for minimally-invasive surgeries, the rising geriatric population, and the technological advancements in the devices used for this treatments are the major drivers for the global varicose vein’s treatment market.

Who are the top players operating in the Varicose Veins Treatment Market?

Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc, Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System), are the leading players operating in the Global Varicose Veins Treatment Market.